Researchers at Tufts University School of Medicine revealed that Borrelia burgdorferi infection induces characteristic reprogramming in bone marrow cells, according to a study published in iScience.
The bacterium causing Lyme disease leaves lasting marks on the immune system. These changes occur inside bone marrow cells. This shift alters future immune responses.
“A lifetime of infections and inflammatory exposures creates little editing marks, called epigenetic changes, in the immune system’s record of all it has encountered so far,” said Tanja Petnicki-Ocwieja, study senior author and research assistant professor of molecular biology and microbiology at the School of Medicine.
“Our study found that epigenetic changes in the bone marrow imprinted by Borrelia burgdorferi infection may essentially revise the immune system’s ‘biography’ and how it responds over time.”
Scientists utilized a mouse model to track bone marrow cells post-infection. The team observed distinct chemical modifications on genes within these cells.
Macrophages showed the most pronounced effects. These early-responding immune cells typically sound alarms to summon other cells. Macrophages from exposed mice produced fewer inflammatory signals for 15 weeks.
“When macrophages first encounter Borrelia burgdorferi, they sound alarm bells that tell other immune cells to come destroy the bacteria,” Petnicki-Ocwieja said. “But after these epigenetic changes are imprinted in the bone marrow, the macrophages appear to sound fewer of those alarms.”
Altered immune reactions appeared even in subjects treated with antibiotics. Early exposure alone triggered these modifications.
“This suggests that an individual’s first exposure to Borrelia burgdorferi is enough to cause long-term effects on the immune response,” said Yuelin Zhong, a Ph.D. student in immunology at the Graduate School of Biomedical Sciences and the study’s first author.
Researchers plan to analyze human blood samples next. Petnicki-Ocwieja will collaborate with Linden Hu, the Paul and Elaine Chervinsky Professor of Immunology at the School of Medicine, to study circulating immune cells.
The team will utilize samples from a multi-institution study led by Tufts. That project tracks patients for up to 15 months following a Lyme disease diagnosis.
“My hope is to sequence these epigenetic marks to create profiles of what Lyme disease does to an individual’s immune system,” Petnicki-Ocwieja said. “We can then use that to see if the profiles belonging to patients who have long-term symptoms look different from patients who have successfully recovered.”
The research paper appeared in the journal iScience in December 2026 under the DOI 10.1016/j.isci.2026.118281.
Suppressed expression of genes involved in the inflammatory response persisted for at least 15 weeks following the initial infection.
Tufts University School of Medicine was established on April 22, 1893, after seven faculty members seceded from the College of Physicians and Surgeons in Boston to form a new school under Tufts College. From its opening in October 1893 with eighty students, the school was coeducational; eight of the twenty-two graduates in its first class were women.
Tanja Petnicki-Ocwieja served as senior author, alongside first author Yuelin Zhong and co-author Linden Hu at Tufts University School of Medicine.